Skip to main content
TH

Thymmune Therapeutics

Cambridge, United States
Last funding
$37.0M
GrantSep 2023

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

Backed byPillar VCAdvanced Research Projects Agency for HealthArranta BioNYBC VenturesGeorge Church

About Thymmune Therapeutics

How much funding has Thymmune Therapeutics raised?

Thymmune Therapeutics has raised $37.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.

Who are Thymmune Therapeutics's investors?

Thymmune Therapeutics's investors include Pillar VC, Advanced Research Projects Agency for Health, Arranta Bio, NYBC Ventures, George Church.

Where is Thymmune Therapeutics headquartered?

Thymmune Therapeutics is headquartered in Cambridge, United States.

What does Thymmune Therapeutics do?

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

What stage is Thymmune Therapeutics at?

Thymmune Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Thymmune Therapeutics — Funding & Investors." VCBacked, September 29, 2023, https://www.vcbacked.co/company/thymmune-therapeutics. Accessed November 16, 2026.
APA
VCBacked. (2023). Thymmune Therapeutics — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/thymmune-therapeutics
Wikipedia (cite web)
{{cite web |title=Thymmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thymmune-therapeutics |website=VCBacked |access-date=November 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Thymmune Therapeutics? Request a listing update

Founder contacts
m***@thymmune.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →